Ignite Creation Date:
2024-05-06 @ 8:11 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06284460
Status:
WITHDRAWN
Last Update Posted:
2024-04-03
First Post:
2024-02-21
Brief Title:
Phase III Study of a Combination of Decitabine and Cedazuridine ASTX727 and ASTX029 an ERK Inhibitor for Patients With RAS Pathway Mutant Myelodysplastic Syndromes and MyelodysplasticMyeloproliferative Neoplasms
Sponsor:
Organization:
MD Anderson Cancer Center